Combined hypertension and orthostatic hypotension in older patients: A treatment dilemma for clinicians

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 3, 2005, Pages 433-440

  Lee, Tom ^a   Donegan, Ciarán ^a   Moore, Allan ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Compression hosiery; Drug induced hypotension; Hypertension; Isolated systolic hypertension; Large artery compliance; Orthostatic hypotension; Syncope; Vascular responsivess

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; LOOP DIURETIC AGENT; LOSARTAN; NICORANDIL; NITRATE; NITRIC OXIDE; PERINDOPRIL; PLACEBO; POTASSIUM CHANNEL STIMULATING AGENT; PRAZOSIN; RAMIPRIL; TERAZOSIN; THIAZIDE DIURETIC AGENT;

AGED; ANKLE PRESSURE; BLOOD VESSEL COMPLIANCE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPRESSION THERAPY; DISEASE PREDISPOSITION; DRUG BIOAVAILABILITY; EVIDENCE BASED MEDICINE; HEART HEMODYNAMICS; HEART PROTECTION; HUMAN; HYPERTENSION; LEG COMPRESSION; LOW DRUG DOSE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; REVIEW; SYNCOPE; VASCULAR RESISTANCE;

AGED; HUMANS; HYPERTENSION; HYPOTENSION, ORTHOSTATIC;

EID: 18844430609     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.3.3.433     Document Type: Review

References (71)

1. Rutan GH, Hermanson B, Bild DE et al. Orthostatic hypotension in older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension 19(1), 508-519 (1992).
2. Applegate WB, Davis BR, Black HR et al. Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J. Am. Geriatr. Soc. 39, 1057-1064 (1991).
3. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. J. Am. Med. Assoc. 289, 2560-2572 (2003)
4. Mancia G, Rosei A, Cifkova R et al. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 21, 1011-1053 (2003)
5. Williams B, Poulter NR, Brown MJ et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. Br. Med. J. 328, 634-640 (2004).
6. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population. Hypertension 25, 305-313 (1995).
7. Hypertension Detection and Follow-up Programme Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Programme I. Reduction in mortality in persons with high blood pressure including mild hypertension. J. Am. Med. Assoc. 242, 2562-2571 (1979).
8. Hypertension Detection and Follow-up Programme Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the hypertension detection and follow-up programme. J. Am. Med. Assoc. 259, 2113-2122 (1988).
9. Sytkowski P, D'Agostino R, Belanger A et al. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. Circulation 93, 697-703 (1996).
10. Hannson L, Zanchetti A, Carruthers SG et al. for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimum treatment (HOT) randomised trial. Lancet 351, 1755-1762 (1998).
11. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N. Engl. J. Med. 342, 145-153 (2000).
12. PROGRESS Collaborative Group. Randomised trial of perindopril-based blood pressure-lowering regimen among 6105 individuals with previous stroke or transient attack. Lancet 358, 1033-1041 (2001).
13. Bulpitt C, Rajkumar C, Beckett N. The need to treat: evidence from controlled clinical trials. In: Hypertension and the Elderly. Potter JF (Ed.). Science Press, London, UK, 17-25 (1999).
14. Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350, 757-764 (1997).
15. Bulpitt CJ, on behalf of HYVET investigators. The Hypertension in the Very Elderly Trial: the importance of the pilot trial and modification to the protocol. Eur. J. Heart 1 (Suppl.), P9-P12 (1999).
16. Sytolic Hypertension in the Elderly Program Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). J. Am. Med. Assoc. 265, 3255-3264 (1991).
17. Franklin SS, Gustin W, Wong ND et al. Hemodynamic patterns of age-related changes in blood pressure. Circulation 96, 308-315 (1997).
18. Tilvis RS, Hakala S-M, Valvanne J, Erkinjuntti T. Postural hypotension and dizziness in a general aged population: a 4-year follow-up of the Helsinki Aging Study. J. Am. Geriatr. Soc. 44, 809-814 (1996).
19. Raiha I, Luutonen S, Piha J et al. Prevalence, predisposing factors and prognostic importance of postural hypotension. Arch. Intern. Med. 155, 930-935 (1995).
20. Tinetti ME, Williams TF. Fall risk index for elderly patients based on number of chronic disabilities. Am. J. Med. 80, 429-434 (1986).
21. Kapoor WN, Karpf M, Wieland S, Peterson J, Levey GS. A prospective evaluation and follow-up of patients with unexplained syncope. N. Engl. J. Med. 309,197-204 (1983).
22. The Consensus Committee Statement of the American Autonomic Society and American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Neurology 46, 1470 (1996).
23. Atkins D, Hanus B, Kapoor W. Syncope and orthostatic hypotension. Am. J. Med. 9, 179-184 (1991).
24. Alli C, Avanzini F, Bettelli G et al. Prevalence and variability of orthostatic hypotension in the elderly. Results of the Italian Study on blood pressure in the elderly. Eur. Heart J. 13, 178-182 (1992).
25. Luukinen H, Koshi K, Laippala P, Sirkka-Lusa K. Prognosis of diastolic and systolic hypotension in older persons. Arch. Intern. Med. 159, 273-279 (1999).
26. Lipsatz LA, Storch HA, Minaker KL, Rowe JW. Intraindividual variability in postural blood pressure in the elderly. Clin. Sci. 69, 337-341 (1985).
27. Gribben B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ. Res. 29, 424-431 (1971).
28. Davis BR, Langford HG, Blaufox MD et al. The association of postural changes in systolic blood pressure and mortality in persons with hypertension: The Hypertension Detection and Follow-up Program experience. Circulation 75, 340-346 (1987).
29. Eigenbrodt ML, Rose KM, Couper DJ et al. Orthostatic hypotension as a risk factor for stroke. Stroke 31, 2307 (2000).
30. Masaki KH, Schatz IJ, Burchfiel CM et al. Orthostatic hypotension predicts mortality in elderly men. Circulation 98, 2290-2295 (1998).
31. Self DA, White CD, Shaffstall RM et al. Differences between syncope resulting from rapid onset acceleration and orthostatic hypotension. Aviat. Space Environ. Med. 67, 547-554 (1996).
32. Asmussen E. The distribution of the blood between the lower extremities and the rest of the body. Acta Physiol. Scand. 5, 31-38 (1943).
33. Ebert TJ, Smith JJ, Barney JA, Merrill DC, Smith GK. The use of thoracic impedance for determining thoracic blood volume in man. Aviat. Space Environ. Med. 57, 49-53 (1986).
34. Ludbrook J. The musculoskeletal pumps of the human lower limb. Am. Heart J. 71, 635-641 (1966).
35. Ludbrook J, Loughlin J. Regulation of volume in the lower-limb postarteriolar vessels in the lower limb. Am. Heart J. 67, 493-507 (1964).
36. Wolthius RA, LeBlanc A, Carpentier WA, Bergman SA Jr. Response of local vascular volumes to lower-body negative pressure stress. Aviat. Space Environ. Med. 46, 697-702 (1975).
37. Asmussen E, Christensen EH, Nielsen M. The regulation of circulation in different postures. Surgery 8, 604-616 (1940).
38. Buckley JC, Peshock RM, Blomqvist CG. Deep venous contribution to hydrostatic blood volume change in the human leg. Am. J. Cardiol. 62, 449-453 (1988).
39. Halliwill JR, Lawlor LA, Eickhoff TJ, Joyner MJ, Mulvagh SI. Reflex responses to regional venous pooling during lower body negative pressure in humans. J. Appl. Physiol. 84, 454-458 (1998).
40. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J. Physiol. 519, 1-10 (1999).
41. Hendricksen O, Skagen K. Local and central sympathetic vasoconstrictor reflexes in human limbs during orthostatic stress. In: Sympathorenal System, Alfred Benzon Symposium. 23rd Edition. Christensen NJ, Hendriksen O, Lassen NA (Eds). Munksgaard, Copenhagen, 83-94 (1993).
42. Rowell LB. Human Cardiovascular Control. Oxford University Press, NY, USA (1993).
43. Chaudhuri KR, Thomaides T, Mathias CJ. Abnormality of superior mesenteric artery blood flow responses in human sympathetic failure. J. Physiol. 457, 477-489 (1992).
44. Blacher J, Asmar R, Djane S, London GM, Safir ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 33, 1111-1117 (1999).
45. Blacher J, London GM, Safar ME, Mourad JJ. Influence of age and end stage renal disease on the stiffness of carotid wall material in hypertension. J. Hypertens. 17, 237-244 (1999).
46. Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin. Sci. 93, 519-522 (1997).
47. Elliott HL, Sumner DJ, McKean K, Reid JL. Effect of age on the responsiveness of vascular α-adrenoceptors in man. J. Cardiovasc. Pharmacol. 4, 388-392 (1982).
48. Moore A, Lyons D. Orthostatic hypotension in older patients. Rev. Clin. Gerontol. 13, 39-53 (2003).
49. Andros E, Detmar-Hanna D, Suteparuk S, Gal S, Gerber JG. The effect of ageing on the pharmacokinetics and pharmacodynamics of prazosin. Eur. J. Clin. Pharmacol. 50, 41-46 (1996).
50. Tsujii T. Comparison of prazosin, terazosin and tainsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Group. Int. J. Urol. 7, 199-205 (2000).
51. Wynne HA, Schofield S. Drug-induced orthostatic hypotension. In: Syncope in the Older Patient: Causes, Investigations and Consequences of Syncope and Falls. Kenny RA Eed.). Chapman and Hall, London, UK, 137-154 (1996).
52. Burton L, Norton M, Newton JL. Are some antihypertensives more prone to induce hypotensive side effects than others? Age Ageing 33, 626-628 (2004).
53. Rosenthal J. A multicenter trial of doxazocin in West Germany. Am. J. Cardiol. 59, 40G-59G (1987).
54. Van Zweiten PA. α-adrenoceptor blocking agents in the treatment of hypertension. In: Hypertension: Pathophysiology, Diagnosis and Management. Second Edition. Laragh JH, Brenner BM (Eds). Raven Press, NY, USA, 2917-2935 (1995).
55. Raftos J. Verapamil in the treatment of angina pectoris. Med. J. Aust. 2, 78-80 (1980).
56. Lewis JG. Adverse reactions to calcium antagonists. Drugs 25, 196-222 (1983).
57. Davidson E, Fuchs J, Rotenberg Z et al. Drug-related syncope. Clin. Cardiol. 12, 577-580 (1989).
58. Reid J, Lees KR, Squire I. First Dose Hypotension and Ace Inhibitors in Heart Failure. Clinical Relevance and Implications. Adis International Ltd, Chester, UK (1995).
59. Squire IB, MacFayden RJ, Reid JL, Devlin A, Lees KR. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. J. Cardiovasc. Pharmacol. 27, 657-666 (1996).
60. Bagger J. Adverse events with first dose perindopril in congestive heart failure. Lancet 350, 520-522 (1997).
61. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in arterial media. Hypertension 32, 170-175 (1998).
62. O'Rourke MF. Pulsatile arterial haemodynamics in hypertension. Aust. NZ J. Med. 6 Suppl. 2, 40-48 (1976).
63. Wilkinson IB, Qasem A, McEniery CM et al. Nitric oxide regulates local arterial distensibility in vivo. Circulation 105, 213-217 (2002).
64. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J. Am. Coll. Cardiol. 37, 975-984 (2001).
65. Gray GA, Webb DJ. The therapeutic potential of endothelin receptor antagonists in cardiovascular disease. Pharmacol Ther. 72, 109-148 (1996).
66. Dahlof B, Devereux RB, Kjeldsen SE et al. Cardiovascular mortality and morbidity in the Losartan Intervention for End point reduction in hypertension (LIFE) study: a randomised trial against atenolol. Lancet 359, 995-1003 (2002).
67. Esler M. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. J. Hypertens. 20(Suppl. 5), S13-S19 (2002).
68. Balt JC, Mathy MJ, Pfaffendorf M, Van Zwieten PA. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan, and embusartan. J. Hypertens. 19(12), 2241-2250 (2001).
69. Henry R, Rowe J, O'Mahony D. Haemodynamic analysis of efficacy of compression hosiery in elderly fillers with orthostatic hypotension. Lancet 354, 45-46 (1999).
70. Hainsworth R. Head-up sleeping for posturally related syncope. Clin. Auton. Res. 10, 225-226 (2000).
71. Omboni S, Smit AA, Lieshout JJ et al. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin. Sci. 101, 619-620 (2001)